Stock ScreenerStock IdeasStrong Balance Sheet And FundamentalsStrong Balance Sheet And Sound FundamentalsCompanies with a strong balance sheet, solid past performance, and high return on equity.
Stock ScreenerStock IdeasStrong Balance Sheet And Fundamentals
Performance Score: >= 60
Healthy Debt to Equity: Pass
High Return on Equity: Pass
Long-term Liabilities: Pass
Short-term Liabilities: Pass
Financials Score: >= 60
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVDA | NVIDIA CORP | $4.91T | $202.78 | $320.56 | 58.08% | Strong Buy | 25 | 29.06% | 24.44% | 195.87% | 147.56% | |||
| DTST | DATA STORAGE CORP | $7.43M | $3.43 | N/A | N/A | N/A | N/A | -73.83% | N/A | -11.56% | -10.72% | |||
| MLI | MUELLER INDUSTRIES INC | $12.80B | $57.86 | $65.00 | 12.34% | Strong Buy | 1 | 9.26% | 6.15% | 30.78% | 26.03% | |||
| ABUS | ARBUTUS BIOPHARMA CORP | $1.02B | $5.14 | N/A | N/A | N/A | N/A | -51.46% | -64.12% | -6.97% | -6.54% | |||
| FSM | FORTUNA MINING CORP | $2.61B | $8.57 | $14.00 | 63.36% | Buy | 1 | N/A | N/A | N/A | N/A | |||
| IDR | IDAHO STRATEGIC RESOURCES INC | $489.00M | $30.93 | N/A | N/A | N/A | N/A | 7.29% | 7.36% | 20.67% | 19.14% | |||
| EVER | EVERQUOTE INC | $875.84M | $24.76 | $26.75 | 8.04% | Strong Buy | 4 | 10.36% | -3.00% | N/A | N/A | |||
| VICR | VICOR CORP | $12.65B | $277.43 | $408.33 | 47.18% | Strong Buy | 3 | 38.53% | 37.52% | 48.82% | 45.73% | |||
| INCY | INCYTE CORP | $23.68B | $118.52 | $108.79 | -8.21% | Buy | 14 | 7.46% | 10.82% | 14.29% | 10.95% | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.52B | $26.41 | $32.92 | 24.64% | Strong Buy | 12 | 13.36% | -12.88% | 28.86% | 22.44% | |||
| RIGL | RIGEL PHARMACEUTICALS INC | $809.65M | $43.76 | $69.00 | 57.68% | Strong Buy | 2 | 7.22% | -42.71% | 19.23% | 15.24% | |||
| PLTR | PALANTIR TECHNOLOGIES INC | $309.35B | $129.04 | $187.42 | 45.24% | Strong Buy | 12 | 45.31% | 45.98% | 144.50% | 119.72% | |||
| RMD | RESMED INC | $30.24B | $208.45 | $262.13 | 25.75% | Buy | 8 | 8.02% | 11.51% | 32.02% | 23.67% | |||
| SPRO | SPERO THERAPEUTICS INC | $122.75M | $2.12 | N/A | N/A | N/A | N/A | -21.95% | 83.29% | N/A | N/A | |||
| NAGE | NIAGEN BIOSCIENCE INC | $277.96M | $3.49 | $10.50 | 200.86% | Strong Buy | 2 | 15.52% | 16.46% | 41.44% | 29.84% | |||
| AMSC | AMERICAN SUPERCONDUCTOR CORP | $1.77B | $37.17 | N/A | N/A | N/A | N/A | 17.19% | -14.97% | 16.03% | 12.04% | |||
| CRDO | CREDO TECHNOLOGY GROUP HOLDING LTD | $49.54B | $265.65 | $268.15 | 0.94% | Strong Buy | 13 | 49.79% | 57.84% | 96.71% | 86.94% | |||
| TPL | TEXAS PACIFIC LAND CORP | $26.95B | $390.77 | $639.00 | 63.52% | Strong Buy | 1 | 23.72% | 27.05% | 45.15% | 40.11% | |||
| MU | MICRON TECHNOLOGY INC | $1.12T | $991.64 | $1.38k | 38.74% | Strong Buy | 26 | 26.94% | 41.03% | 140.63% | 105.62% | |||
| EXEL | EXELIXIS INC | $14.35B | $57.10 | $50.20 | -12.08% | Hold | 10 | 11.54% | 13.98% | 64.63% | 48.24% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $824.06M | $13.94 | $29.29 | 110.09% | Strong Buy | 7 | 29.42% | -5.20% | 81.82% | 60.44% | |||
| WPM | WHEATON PRECIOUS METALS CORP | $50.24B | $110.65 | $163.67 | 47.91% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| DMLP | DORCHESTER MINERALS LP | $1.28B | $26.50 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CALM | CAL-MAINE FOODS INC | $4.04B | $85.35 | $85.00 | -0.41% | Hold | 2 | -6.20% | -39.17% | 9.34% | 8.04% | |||
| FATN | FATPIPE INC | $75.17M | $5.36 | $10.00 | 86.57% | Strong Buy | 2 | 29.93% | -7.84% | 11.35% | 8.29% | |||
| RDDT | REDDIT INC | $38.56B | $200.31 | $229.94 | 14.79% | Buy | 18 | 30.36% | 30.21% | 72.44% | 66.11% | |||
| MNST | MONSTER BEVERAGE CORP | $94.43B | $96.55 | $92.25 | -4.45% | Strong Buy | 12 | 9.44% | 12.70% | 37.87% | 30.48% | |||
| NTES | NETEASE INC | $85.65B | $133.91 | $132.00 | -1.43% | Hold | 1 | 104.37% | 116.23% | N/A | N/A | |||
| ALAB | ASTERA LABS INC | $71.55B | $417.45 | $267.67 | -35.88% | Buy | 15 | 42.05% | 54.52% | 51.53% | 46.40% | |||
| SEIC | SEI INVESTMENTS CO | $11.39B | $94.73 | $112.75 | 19.02% | Strong Buy | 4 | 8.46% | 8.36% | 43.53% | 32.57% | |||
| NSSC | NAPCO SECURITY TECHNOLOGIES INC | $1.29B | $36.09 | $51.33 | 42.24% | Strong Buy | 3 | 15.08% | 36.15% | 38.74% | 31.02% | |||
| CHCI | COMSTOCK HOLDING COMPANIES INC | $161.28M | $15.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| ELMD | ELECTROMED INC | $379.39M | $45.82 | $38.00 | -17.07% | Strong Buy | 2 | 8.33% | 4.29% | 18.90% | 15.62% | |||
| ARGX | ARGENX SE | $56.28B | $909.49 | $1.04k | 14.58% | Strong Buy | 11 | N/A | N/A | N/A | N/A | |||
| IRMD | IRADIMED CORP | $1.25B | $98.04 | $116.00 | 18.32% | Strong Buy | 1 | 9.86% | 13.78% | N/A | N/A | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.13B | $16.59 | N/A | N/A | N/A | N/A | 15.51% | -7.34% | 31.51% | 24.70% | |||
| COCO | VITA COCO COMPANY INC | $4.07B | $71.25 | $73.80 | 3.58% | Strong Buy | 5 | 12.16% | 15.52% | N/A | N/A | |||
| USLM | UNITED STATES LIME & MINERALS INC | $2.85B | $99.20 | $138.00 | 39.11% | Strong Buy | 1 | 14.50% | 12.99% | 27.35% | 25.33% | |||
| XNET | XUNLEI LTD | $371.74M | $5.84 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SII | SPROTT INC | $2.83B | $109.74 | $230.00 | 109.59% | Buy | 1 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.